Home / News / Publications

Publications

Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy.

Hoang MV, Smith LE, Senger DR. Angiogenesis. 2010 Sep;13(3):269-77. doi: 10.1007/s10456-010-9184-y. Epub 2010 Sep 1.

Progress Report The MacTel Project.

Gillies MC. Retina Today 2010;Apr:35-37.

Structure-Function Correlation of the Human Central Retina.

Issa PC, Troeger E, Finger R, Holz FG, Wilke R, Scholl HPN. PLOS ONE 2010;5(9):1-11.

Analysis of candidate genes for macular telangiectasia type 2.

Parmalee NL, Schubert C, Merriam JE, Allikmets K, Bird AC, Gillies MC, Peto T, Figueroa M, Friedlander M, Fruttiger M, Greenwood J, Moss SE, Smith LE, Toomes C, Inglehearn CF, Allikmets R. Mol Vis. 2010 Dec 14;16:2718-26.

Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Dorrell MI, Aguilar E, Jacobson R, Yanes O, Gariano R, Heckenlively J, Banin E, Ramirez GA, Gasmi M, Bird A, Siuzdak G, Friedlander M. J Clin Invest. 2009 Mar;119(3):611-23. doi: 10.1172/JCI35977. Epub 2009 Feb 2.

Familial Asymptomatic Macular Telangiectasia Type 2.

Gillies MC, Zhu M, Chew E, Barthelmes D, Hughes E, Ali H, Holz FG, Scholl H, Issa PC. Ophthalmology 2009;116(12):2422-2429.

Reading Performance is Reduced by Parafoveal Scotomas in Patients with Macular Telangiectasia Type 2.

Finger RP, Issa PC, Fimmers R, Holz FG, Rubin GS, Scholl HPN. Investigative Ophthalmology & Visual Science 2009;50(3):1366-1370.

Retinal Vascular Caliber and Macular Telangiectasia Type 2.

Tikellis G, Gillies MC, Guymer RH, McAllister IL, Shaw JE, Wong TY. Ophthalmology 2009;116(2):319-323.

Quantitative OCT Analysis of Idiopathic Perifoveal Telangiectasia.

Barthelmes D, Gillies MC, Sutter FKP. Investigative Ophthalmology & Visual Science 2008;49(5):2156-2162.

The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project – MacTel Project Report No. 1.

Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa M, Harrington MW. Investigative Ophthalmology & Visual Science 2008;49(10):4340-4346.